A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan

Vaccine: X · Published 2026-07-29 · DOI 10.1016/j.jvacx.2026.100885

Free full text

Authors (14)

Takashi Ogawa, Tsuyoshi Ando, Eiko Iwasa, Chika Uchiyama, Kengo Kawachi, Sunyi Joo, Kao Hayata, Hiroyuki Hiramatsu, Shun Masuta, Jurika Murakami, Junichi Fukuchi, Yoko Yabuki, Kenji Sawanobori, Yuji Matsukura

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ogawa, T., Ando, T., Iwasa, E., et al. (2026). A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan. Vaccine: X. https://doi.org/10.1016/j.jvacx.2026.100885

Related articles